These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22405970)

  • 1. The Rare Diseases Clinical Research Network Contact Registry update: features and functionality.
    Richesson RL; Sutphen R; Shereff D; Krischer JP
    Contemp Clin Trials; 2012 Jul; 33(4):647-56. PubMed ID: 22405970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants.
    Richesson RL; Lee HS; Cuthbertson D; Lloyd J; Young K; Krischer JP
    Contemp Clin Trials; 2009 Jan; 30(1):55-62. PubMed ID: 18804556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rare Diseases Clinical Research Network: a model for clinical trial readiness.
    Lumsden JM; Urv TK
    Ther Adv Rare Dis; 2023; 4():26330040231219272. PubMed ID: 38152157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network.
    Merkel PA; Manion M; Gopal-Srivastava R; Groft S; Jinnah HA; Robertson D; Krischer JP;
    Orphanet J Rare Dis; 2016 May; 11(1):66. PubMed ID: 27194034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rare Diseases Clinical Research Network's organization and approach to observational research and health outcomes research.
    Krischer JP; Gopal-Srivastava R; Groft SC; Eckstein DJ;
    J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S739-44. PubMed ID: 25029976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study.
    Tosi LL; Floor MK; Dollar CM; Gillies AP; ; Hart TS; Cuthbertson DD; Sutton VR; Krischer JP
    Orphanet J Rare Dis; 2019 Jan; 14(1):23. PubMed ID: 30696467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The North American mitochondrial disease registry.
    Rosales XQ; Thompson JLP; Haas R; Van Hove JLK; Karaa A; Krotoski D; Engelstad K; Buchsbaum R; DiMauro S; Hirano M;
    J Transl Genet Genom; 2020; 4():81-90. PubMed ID: 32601614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NIH Office of Rare Diseases Research patient registry Standard: a report from the University of New Mexico's Oculopharyngeal Muscular Dystrophy Patient Registry.
    Daneshvari S; Youssof S; Kroth PJ
    AMIA Annu Symp Proc; 2013; 2013():269-77. PubMed ID: 24551336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.
    De Antonio M; Dogan C; Daidj F; Eymard B; Puymirat J; Mathieu J; Gagnon C; Katsahian S; ; Hamroun D; Bassez G
    Orphanet J Rare Dis; 2019 Jun; 14(1):122. PubMed ID: 31159885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).
    Rubinstein YR; Groft SC; Bartek R; Brown K; Christensen RA; Collier E; Farber A; Farmer J; Ferguson JH; Forrest CB; Lockhart NC; McCurdy KR; Moore H; Pollen GB; Richesson R; Miller VR; Hull S; Vaught J
    Contemp Clin Trials; 2010 Sep; 31(5):394-404. PubMed ID: 20609392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
    Rubinstein YR; Posada de la Paz M; Mora M
    Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modular approach to disease registry design: successful adoption of an internet-based rare disease registry.
    Bellgard MI; Macgregor A; Janon F; Harvey A; O'Leary P; Hunter A; Dawkins H
    Hum Mutat; 2012 Oct; 33(10):E2356-66. PubMed ID: 22753342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient registries: utility, validity and inference.
    Richesson R; Vehik K
    Adv Exp Med Biol; 2010; 686():87-104. PubMed ID: 20824441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for the design and implementation of a participant recruitment registry for clinical studies of older adults.
    Dowling NM; Olson N; Mish T; Kaprakattu P; Gleason C
    Clin Trials; 2012 Apr; 9(2):204-14. PubMed ID: 22273586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
    de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
    Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system.
    Berger A; Rustemeier AK; Göbel J; Kadioglu D; Britz V; Schubert K; Mohnike K; Storf H; Wagner TOF
    Orphanet J Rare Dis; 2021 May; 16(1):198. PubMed ID: 33933089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the Rare Disease Registry of the Italian Region Friuli Venezia Giulia.
    Valent F; Deroma L; Moro A; Ciana G; Martina P; De Martin F; Michelesio E; Da Riol MR; Macor D; Bembi B;
    Value Health; 2019 Sep; 22(9):1003-1011. PubMed ID: 31511176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.